AJO LP’s Abiomed Inc ABMD Stock Holding History

AJO LP’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,264	Closed	-$2.36M	–	762
2019 Q1	$2.36M	Sell	8,264 -2,371	-22%	-$788K	0.01%	436
2018 Q4	$3.46M	Buy	10,635 +2,474	+30%	+$859K	0.02%	380
2018 Q3	$3.67M	Buy	+8,161	New	+$3.22M	0.02%	404

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

AJO LP's ABMD Position: Q2 2019 in Review

AJO LP sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 8,264 shares — an estimated $2.36M sold.

AJO LP first reported a position in ABMD in Q3 2018 and held it in 3 quarters. The position peaked at $3.67M in Q3 2018. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

AJO LP reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
AJO LP sold 8,264 Abiomed Inc shares in Q2 2019, an estimated $2.36M.
AJO LP first reported a position in Abiomed Inc in Q3 2018 and held it in 3 quarters.
AJO LP's Abiomed Inc position peaked at $3.67M in Q3 2018.
483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on AJO LP's 13F filing for Q2 2019, filed 14 Aug 2019.